Testing the Addition of an Anti-Cancer Drug, Camonsertib, to Radiation Therapy for Recurrent Head and Neck Squamous Cell Carcinoma
National Cancer Institute (NCI)
National Cancer Institute (NCI)
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Dana-Farber Cancer Institute
Vanderbilt-Ingram Cancer Center
EpiBiologics
Fox Chase Cancer Center
NRG Oncology
Radiopharm Theranostics, Ltd
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
NYU Langone Health
Washington University School of Medicine
Centre Georges Francois Leclerc
University Hospital, Brest
University of Maryland, Baltimore
OHSU Knight Cancer Institute
University Health Network, Toronto
Yale University
National Medical Research Radiological Centre of the Ministry of Health of Russia
University of Miami
Sir Run Run Shaw Hospital
Massachusetts General Hospital
Zhejiang Cancer Hospital
NYU Langone Health
UNC Lineberger Comprehensive Cancer Center
Sun Yat-sen University
Qilu Pharmaceutical Co., Ltd.
National Cancer Institute, Egypt
Sun Yat-sen University
Onchilles Pharma Inc
Medical University of South Carolina
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Kaohsiung Medical University Chung-Ho Memorial Hospital
Regeneron Pharmaceuticals
Dartmouth-Hitchcock Medical Center
Groupe Oncologie Radiotherapie Tete et Cou
OncoHost Ltd.
UNICANCER
University of Cincinnati
Case Comprehensive Cancer Center
Insel Gruppe AG, University Hospital Bern
UNICANCER
Indiana University
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Al-Azhar University
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Beijing Tongren Hospital
Shanghai Bao Pharmaceuticals Co., Ltd.
Qilu Hospital of Shandong University
Fudan University
Sun Yat-sen University